Ovarian PRP (Platelet-Rich Plasma) is an emerging regenerative treatment for women with diminished ovarian reserve (DOR) or premature ovarian insufficiency (POI). Growth factors derived from the patient’s own blood are injected directly into the ovarian tissue to stimulate follicle development and improve egg quality.
Ovarian Exosome + PRP
Combines PRP with exosomes carrying signalling molecules that may further enhance cellular regeneration within ovarian tissue, offering a more potent regenerative effect.
Who May Benefit?
Women with low AMH, high FSH, poor ovarian response in previous IVF cycles, or premature ovarian insufficiency.
Important Note
These treatments are considered experimental. Emerging evidence is encouraging, but results vary. A detailed consultation with Assist. Prof. Dr. Muzaffer Uçarer is essential to determine individual suitability.
Contact UCARER Women’s Health to book your consultation.